Disfuno das clulas beta: necessidade de insulina a longo prazo secreo de insulina defeituosa Resulta em hiperglicemia A abordagem farmacolgica pode ter como alvo a: Libertao de insulina Resistncia insulina Libertao de glucagon Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal glucagon-like peptides
Schechter M, Fischer M, Mosenzon O (2022) Preventing all-cause hospitalizations in type 2 diabetes with sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a narrative review and proposed clinical approach
Many patients abandon the drug in a matter of months, due to cost, availability, and side effects
Digestive Problems Linked to Wegovy Stomach paralysis Gastroparesis Gastric stasis Ileus (lack of movement of food through the intestines) Intestinal pseudo obstruction Severe nausea And more Lawsuits Claim Wegovy Causes Stomach Paralysis Stomach paralysis (gastroparesis) has been reported by many patients on GLP-1 diabetes drugs, including Wegovy and Ozempic
Not surprisingly, a subset of DPP-4 inhibitors evaluated during pre-clinical development were found to suppress DPP-8 and/or DPP-9 activity, causing severe toxicities, including weakened T cell activation and proliferation, impaired preadipocyte differentiation (Han et al., 2015), enlarged lymph nodes, splenomegaly, etc
